55 results on '"Wimo, A"'
Search Results
2. Response and Adherence of Nursing Home Residents to a Nutrition/Exercise Intervention
3. Profiles of Met and Unmet Needs in People with Dementia According to Caregivers’ Perspective: Results from a European Multicenter Study
4. Effect of Sit-to-Stand Exercises Combined With Protein-Rich Oral Supplementation in Older Persons: The Older Person's Exercise and Nutrition Study
5. Assessing cost-effectiveness of early intervention in Alzheimer's disease: An open-source modeling framework
6. Using an Integrated Clinical and Functional Assessment Tool to Describe the Use of Social and Medical Care in an Urban Community-Dwelling Swedish Older Population
7. The MOPEAD project: Advancing patient engagement for the detection of “hidden” undiagnosed cases of Alzheimer's disease in the community
8. Apolipoprotein E genotypes and longevity across dementia disorders
9. CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients
10. Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease
11. The worldwide costs of dementia 2015 and comparisons with 2010
12. The Use and Costs of Formal Care in Newly Diagnosed Dementia: A Three-Year Prospective Follow-Up Study
13. Application of Resource Utilization in Dementia (RUD) instrument in a global setting
14. The worldwide economic impact of dementia 2010
15. The global prevalence of dementia: A systematic review and metaanalysis
16. Costs of Care of Agitation Associated With Dementia in 8 European Countries: Results From the RightTimePlaceCare Study
17. Predictors of costs of care in Alzheimer’s disease: A multinational sample of 1222 patients
18. The worldwide societal costs of dementia: Estimates for 2009
19. QUANTIFYING AND DESCRIBING THE NATURAL HISTORY OF AD AND ECONOMIC EFFECTS OF HYPOTHETICAL INTERVENTIONS
20. ASSOCIATION WITH REDUCED MORTALITY USING CHOLINESTERASE INHIBITORS IN PATIENTS WITH DEMENTIA: DATA FROM SVEDEM, THE SWEDISH DEMENTIA REGISTRY
21. A NEW OPEN-SOURCE MODELING FRAMEWORK TO ASSESS COST EFFECTIVENESS OF EARLY INTERVENTION IN ALZHEIMER’S DISEASE
22. STRUCTURAL UNCERTAINTY AND CROSS-VALIDATION OF DECISION MODELS IN THE AD SETTING: ANSWERING QUESTIONS FROM POLICY MAKERS ON THE RELIABILITY OF HEALTH-ECONOMIC MODELS
23. Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimer's disease biomarkers for hypothetical disease-modifying treatment decision in mild cognitive impairment
24. DEMENTIA INFORMAL CARE COSTS IN THE SLOVENIAN CENTRE FOR COGNITIVE IMPAIRMENTS
25. MODELS OF PATIENT ENGAGEMENT IN ALZHEIMER’S DISEASE (MOPEAD): A EUROPEAN MULTINATIONAL PROJECT TO DEVELOP AND TEST INNOVATIVE PATIENT ENGAGEMENT STRATEGIES
26. CHALLENGES AND RECOMMENDATIONS FOR THE HEALTH-ECONOMIC EVALUATION OF PRIMARY PREVENTION PROGRAMS FOR DEMENTIA
27. PRM111 - Current Issues and Future Research Priorities for Health Economic Modelling of at Risk Population for Alzheimer’s Disease/Dementia
28. PRM24 - How to deal with missing longitudinal data in cost of illness models in alzheimer’s disease – suggestions from the geras study results
29. PND48 Health State Values in Alzheimer'S Disease – Baseline Results From a Large Prospective Observational Study in Three European Countries (GERAS)
30. PHS50 Health Care Resource Use and Cost in Alzheimer's Disease in Three European Countries – Baseline Findings of the GERAS Study
31. 84 Global pharmacoeconomics of Alzheimer's disease in light of potential cost effectiveness of disease modifying treatment
32. PMH15 Mortality in relation to Disease Severity in Subjects with Dementia
33. Dementia work-up is more costly in men than in women
34. The use of drugs in demented and non-demented people according to living situation; a comparison between rural and urban areas—results from SNAC, a population-based multicenter study
35. Changes in care patterns over time in relation to cognitive and physical functioning of non demented and demented elderly people: Results from a 3-year follow-up population-based study
36. Cross cultural perspectives on assessment and treatment of Alzheimer's disease with a focus on economic evaluation
37. Trends in informal care in Sweden: Is it decreasing? Cross-sectional studies with the RUD instrument
38. Health-economic benefits of memantine treatment: Translating symptomatic effects into cost savings
39. P4-106: Cognitive functioning in old age: Temporal trends in a rural area in Sweden
40. P4-049: The impact of dementia on life expectancy after age 75
41. P3-441: Net costs of dementia in Sweden: An incidence-based 10-year simulation study
42. PND67 - How Useful are Eq-5d And Zbi In Assessing The Impact of Caring for Alzheimer’s Disease Patients?
43. PND64 - Comparing Resource Use In Alzheimer’s Disease Across Three European Countries - 18-Month Results of The Geras Study
44. Brain Health: A Primary Health Care Viewpoint
45. P1-146: Dementia and community costs in an area with a dementia program targeting early intervention. A study with an economic focus
46. O1-05-08: The worldwide directs costs and costs of informal care of dementia
47. The worldwide costs of dementia
48. P2-396 Societal costs of dementia in Sweden: an application of the rud-instrument in a population-based study
49. PNP13: CAREGIVER HEALTH BENEFITS AND ASSOCIATED REDUCTIONS IN HEALTHCARE COSTS AS A CONSEQUENCE OF TREATING PATIENTS WITH DONEPEZIL
50. Response to donepezil is not predicted by apolipoprotein E genotype and/or gender
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.